Form 4: Xylem Inc. Executive Claudia S. Toussaint Reports Stock Transactions
SEC Form 4 Filing
Claudia S. Toussaint, SVP and CPSO of Xylem Inc., reports acquisition and disposal of company stock and stock options on March 1, 2024, according to a Form 4 filing.
Summary
- On March 1, 2024, Claudia S. Toussaint, SVP and CPSO of Xylem Inc., engaged in multiple transactions involving Xylem's common stock.
- These transactions included the acquisition of shares through the vesting of performance-based stock units and restricted stock units, as well as the withholding of shares to cover tax liabilities.
- Toussaint acquired 2,934 shares and 1,805 shares of common stock upon vesting of performance-based stock units at a price of $127.94.
- She also acquired 1,759 restricted stock units.
- 2,077 shares and 1,055 shares were withheld to cover tax liabilities related to the vesting of stock units at a price of $127.94.
- Additionally, Toussaint was granted 5,949 non-qualified stock options exercisable beginning March 1, 2025.
- Following these transactions, Toussaint directly owns 8,247 shares of common stock and indirectly owns 31,431 shares through the Claudia S. Toussaint Revocable Trust.
- She also directly owns 5,949 stock options.
Sentiment
Score: 6
Explanation: Neutral sentiment as the filing primarily reports routine stock transactions related to executive compensation. The vesting of performance-based units suggests positive performance, but the tax withholding is a neutral event.
Positives
- The vesting of performance-based stock units indicates that performance criteria related to ROIC and Total Shareholder Return were met.
- The grant of restricted stock units and stock options aligns Toussaint's interests with those of the shareholders.
Future Outlook
The restricted stock units and stock options are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026, and March 1, 2027.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's future performance.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are standard practice among publicly traded companies like Xylem, and are comparable to those offered by companies such as Danaher, Roper Technologies, and Advanced Drainage Systems.
- The vesting schedules and performance-based criteria are also typical within the industry, designed to align executive incentives with shareholder value creation.
Stakeholder Impact
- The vesting of stock units and granting of stock options align management's interests with those of shareholders.
- Tax liabilities resulting from vesting impact government revenue.
Next Steps
- Restricted stock units and stock options will continue to vest in the future.
Key Dates
| Date | Description |
|---|---|
| 2016-02-24 | Date of Amended and Restated Xylem Omnibus Incentive Plan. |
| 2021-03-01 | Grant date of performance-based stock units and restricted stock units. |
| 2022-03-01 | Grant date of restricted stock units. |
| 2023-03-01 | Grant date of restricted stock units. |
| 2023-11-07 | Date of Power of Attorney. |
| 2024-03-01 | Date of stock transactions, vesting of stock units, and grant of stock options. |
| 2024-03-05 | Date of Form 4 filing. |
| 2025-03-01 | First vesting date for restricted stock units and stock options. |
| 2026-03-01 | Second vesting date for restricted stock units and stock options. |
| 2027-03-01 | Third vesting date for restricted stock units and stock options. |
| 2034-03-01 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.